Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.
…, A Gülfe, MC Kapetanovic, IF Petersson… - The Journal of …, 2005 - jrheum.org
OBJECTIVE: To investigate the risk of cardiovascular disease (CVD) in patients with rheumatoid
arthritis (RA) treated with tumor necrosis factor (TNF) inhibitors, compared to a standard …
arthritis (RA) treated with tumor necrosis factor (TNF) inhibitors, compared to a standard …
Chronic musculoskeletal pain, prevalence rates, and sociodemographic associations in a Swedish population study.
…, PER Herrström, K Högström, IF Petersson… - The Journal of …, 2001 - jrheum.org
OBJECTIVE: To estimate the prevalence of chronic regional and widespread musculoskeletal
pain in a sample of the general adult population and study the association to age, sex, …
pain in a sample of the general adult population and study the association to age, sex, …
Radiographic osteoarthritis of the knee classified by the Ahlbäck and Kellgren & Lawrence systems for the tibiofemoral joint in people aged 35–54 years with chronic …
IF Petersson, T Boegård, T Saxne, AJ Silman… - Annals of the …, 1997 - ard.bmj.com
OBJECTIVES To determine the prevalence of tibiofemoral radiographic knee osteoarthritis (OA)
in people aged 35–54 years associated with chronic (> 3 months) knee pain using two …
in people aged 35–54 years associated with chronic (> 3 months) knee pain using two …
[HTML][HTML] Current and future impact of osteoarthritis on health care: a population-based study with projections to year 2032
A Turkiewicz, IF Petersson, J Björk, G Hawker… - Osteoarthritis and …, 2014 - Elsevier
Objective To estimate the current and future (to year 2032) impact of osteoarthritis (OA) health
care seeking. Method Population-based study with prospectively ascertained data from …
care seeking. Method Population-based study with prospectively ascertained data from …
Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded …
…, K Forslind, K Albertsson, S Ernestam, IF Petersson… - The Lancet, 2012 - thelancet.com
Background Analysis of the Swedish Farmacotherapy (Swefot) trial at 12 months showed
that the addition of an anti-tumour-necrosis-factor agent gave an improved clinical outcome …
that the addition of an anti-tumour-necrosis-factor agent gave an improved clinical outcome …
Prevalence of fibromyalgia and chronic widespread pain
L Lindell, S Bergman, IF Petersson… - … journal of primary …, 2000 - Taylor & Francis
Objective - To explore the prevalence of fibromyalgia and chronic widespread musculoskeletal
pain in a general population using the criteria of the American College of Rheumatology …
pain in a general population using the criteria of the American College of Rheumatology …
Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis
…, C Turesson, JÅ Nilsson, IF Petersson… - Annals of the …, 2007 - ard.bmj.com
Objective: To assess mortality in patients with rheumatoid arthritis (RA) treated with tumour
necrosis factor (TNF) inhibitors, compared with a standard RA population. Methods: Patients …
necrosis factor (TNF) inhibitors, compared with a standard RA population. Methods: Patients …
Population‐based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis
A Bremander, IF Petersson, S Bergman… - Arthritis care & …, 2011 - Wiley Online Library
Objective To study the rate of common comorbidities and cardiovascular disease in patients
with ankylosing spondylitis (AS) compared with the general population seeking health care. …
with ankylosing spondylitis (AS) compared with the general population seeking health care. …
Chronic widespread pain: a three year followup of pain distribution and risk factors.
…, P Herrström, LT Jacobsson, IF Petersson - The Journal of …, 2002 - jrheum.org
OBJECTIVE: To describe the change of pain reports over time in 3 cohorts derived from the
general population: (1) no chronic pain (NCP; n = 1156); (2) chronic regional pain (CRP; n = …
general population: (1) no chronic pain (NCP; n = 1156); (2) chronic regional pain (CRP; n = …
Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial
…, S Ernestam, P Geborek, IF Petersson… - Annals of the …, 2011 - ard.bmj.com
Predictors of response to methotrexate in early DMARD naïve rheumatoid arthritis: results
from the initial open-label phase of the SWEFOT trial | Annals of the Rheumatic Diseases Skip …
from the initial open-label phase of the SWEFOT trial | Annals of the Rheumatic Diseases Skip …